185 related articles for article (PubMed ID: 33678741)
1. Recurrence of 2,8-dihydroxyadenine Crystalline Nephropathy in a Kidney Transplant Recipient: A Case Report and Literature Review.
Cheng Y; Guo L; Wang M; Chen J; Wang R
Intern Med; 2021 Aug; 60(16):2651-2657. PubMed ID: 33678741
[TBL] [Abstract][Full Text] [Related]
2. Rare crystalline nephropathy leading to acute graft dysfunction: a case report.
Bagai S; Khullar D; Bansal B
BMC Nephrol; 2019 Nov; 20(1):428. PubMed ID: 31752739
[TBL] [Abstract][Full Text] [Related]
3. Adenine phosphoribosyl transferase deficiency leads to renal allograft dysfunction in kidney transplant recipients: a systematic review.
Rashid I; Verma A; Tiwari P; D'Cruz S
J Bras Nefrol; 2022; 44(3):403-416. PubMed ID: 35635787
[TBL] [Abstract][Full Text] [Related]
4. 2,8-Dihydroxyadenine Nephropathy Identified as Cause of End-Stage Renal Disease After Renal Transplant.
George SA; Al-Rushaidan S; Francis I; Soonowala D; Nampoory MRN
Exp Clin Transplant; 2017 Oct; 15(5):574-577. PubMed ID: 27447713
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.
Bollée G; Cochat P; Daudon M
Can J Kidney Health Dis; 2015; 2():31. PubMed ID: 26380104
[TBL] [Abstract][Full Text] [Related]
6. Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation.
Nanmoku K; Kurosawa A; Shinzato T; Shimizu T; Kimura T; Yagisawa T
Intern Med; 2017; 56(11):1387-1391. PubMed ID: 28566603
[TBL] [Abstract][Full Text] [Related]
7. A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan.
Takeuchi H; Kaneko Y; Fujita J; Yoshida O
J Urol; 1993 Apr; 149(4):824-6. PubMed ID: 8455250
[TBL] [Abstract][Full Text] [Related]
8. 2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant.
Glicklich D; Gruber HE; Matas AJ; Tellis VA; Karwa G; Finley K; Salem C; Soberman R; Seegmiller JE
Q J Med; 1988 Oct; 68(258):785-93. PubMed ID: 3077470
[TBL] [Abstract][Full Text] [Related]
9. [2,8-dihydroxyadenine urolithiasis: case report and literature review].
Arancio M; Ranzoni S; Delsignore A; Landi G; Maffei N; Marcato M; Mina A; Martinengo C
Urologia; 2011; 78(4):305-9. PubMed ID: 21553389
[TBL] [Abstract][Full Text] [Related]
10. Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction.
Kaartinen K; Hemmilä U; Salmela K; Räisänen-Sokolowski A; Kouri T; Mäkelä S
J Am Soc Nephrol; 2014 Apr; 25(4):671-4. PubMed ID: 24459232
[TBL] [Abstract][Full Text] [Related]
11. [2,8-dihydroxyadenine urolithiasis due to partial deficiency of adenine phosphoribosyltransferase: a case report].
Ohne T; Fujito A; Koga K; Imaide Y; Uchida M
Hinyokika Kiyo; 1998 Oct; 44(10):725-8. PubMed ID: 9850838
[TBL] [Abstract][Full Text] [Related]
12. Four consecutive renal transplantations in a patient with adenine phosphoribosyltransferase deficiency.
Eller P; Rosenkranz AR; Mark W; Theurl I; Laufer J; Lhotta K
Clin Nephrol; 2004 Mar; 61(3):217-21. PubMed ID: 15077874
[TBL] [Abstract][Full Text] [Related]
13. Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.
Zaidan M; Palsson R; Merieau E; Cornec-Le Gall E; Garstka A; Maggiore U; Deteix P; Battista M; Gagné ER; Ceballos-Picot I; Duong Van Huyen JP; Legendre C; Daudon M; Edvardsson VO; Knebelmann B
Am J Transplant; 2014 Nov; 14(11):2623-32. PubMed ID: 25307253
[TBL] [Abstract][Full Text] [Related]
14. Obstructive uropathy and severe acute kidney injury from renal calculi due to adenine phosphoribosyltransferase deficiency.
Chong SL; Ng YH
World J Pediatr; 2016 May; 12(2):243-5. PubMed ID: 26684317
[TBL] [Abstract][Full Text] [Related]
15. An Unusual Course of a 2,8-Dihydroxyadeninuria Crystalline Nephropathy Secondary to Adenine Phosphoribosyltransferase Deficiency.
Nourié N; Nassereddine H; Azar H
Nephron; 2021; 145(5):503-507. PubMed ID: 34044400
[TBL] [Abstract][Full Text] [Related]
16. Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency.
Runolfsdottir HL; Palsson R; Agustsdottir IMS; Indridason OS; Li J; Dao M; Knebelmann B; Milliner DS; Edvardsson VO
Transplantation; 2020 Oct; 104(10):2120-2128. PubMed ID: 31880754
[TBL] [Abstract][Full Text] [Related]
17. Adenine phosphoribosyltransferase deficiency.
Bollée G; Harambat J; Bensman A; Knebelmann B; Daudon M; Ceballos-Picot I
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1521-7. PubMed ID: 22700886
[TBL] [Abstract][Full Text] [Related]
18. Long-term renal outcomes of APRT deficiency presenting in childhood.
Runolfsdottir HL; Palsson R; Agustsdottir IM; Indridason OS; Edvardsson VO
Pediatr Nephrol; 2019 Mar; 34(3):435-442. PubMed ID: 30443743
[TBL] [Abstract][Full Text] [Related]
19. A Japanese boy with adenine phosphoribosyltransferase (APRT) deficiency caused by compound heterozygosity including a novel missense mutation in APRT gene.
Nozue H; Kamoda T; Saitoh H; Ichikawa K; Taniguchi A
Acta Paediatr; 2011 Dec; 100(12):e285-8. PubMed ID: 21635362
[TBL] [Abstract][Full Text] [Related]
20. Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant.
Gagné ER; Deland E; Daudon M; Noël LH; Nawar T
Am J Kidney Dis; 1994 Jul; 24(1):104-7. PubMed ID: 8023815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
